"ATTAINMAINTAIN showed that orforglipron, a once-daily oral GLP-1, helped people maintain the weight they worked hard to lose." This data provides the first robust, Phase 3 evidence that an oral "step-down" or "switch" strategy is not just feasible but effective, offering a new pathway for the long-term management of obesity
Non-GMO, vegetarian-friendly, third-party tested
If GLP-1 therapy is approved, PlexusDx can coordinate with your bariatric team to provide detailed dosing information, side-effect monitoring guidance, and access to HSA/FSA-eligible medication without insurance barriersensuring transparent pricing (your dose may need to go up, but your monthly cost won't) as your treatment progresses
For maximum effect, leave on skin for 2-3 mins before rinsing
Determination of placental NO
Don't stop without consulting your provider